Please assess the completion status of the following clinical trial:

Trial Title: Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Woman currently using MIRENA for contraception or menorrhagia with duration use between 4 years 3 months and 4 years 9 months and willingness to continue with the method.~* Normal size uterus at insertion, corresponding to sound measure of 6-10 cm.~* Clinically normal cervical smear result within 12 preceding months or at screening.~* Clinically normal breast examination findings. For patients \>/= 40 years at screening, a clinically normal mammography result within 12 preceding months or at screening is required.~Exclusion Criteria:~* Menopausal symptoms impairing patient's quality of life or current estrogen therapy for menopausal symptoms.~* Known or suspected pregnancy.~* Any distortion of the uterine cavity, including congenital or acquired uterine anomalies and fibroids distorting the uterine cavity.~* Current or recurrent pelvic inflammatory disease.~* Abnormal uterine bleeding of unknown origin.~* Acute cervicitis or vaginitis not responding to treatment.~* History of, diagnosed or suspected genital or other malignancy (excluding treated squamous cell carcinoma of the skin), and untreated cervical dysplasia.~* Any active acute liver disease or liver tumor.

- Gender: FEMALE
- Minimum Age: 23 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: EXPERIMENTAL): None
- Arm 2 (Type: PLACEBO_COMPARATOR): None
- Arm 3 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).